Recommendations: Hypertension/Blood Pressure Control Treatment (4) Pharmacologic therapy for patients with diabetes and hypertension – A regimen that includes either an ACE inhibitor or angiotensin II receptor blocker – If one class is not tolerated, the other should be substituted Multiple drug therapy (two or more agents at maximal doses) is generally required to achieve blood pressure targets (B) ADA.
{"Image DocumentName": "Recommendations: Hypertension/Blood Pressure Control", "Image ImageDescription": "Treatment (4) Pharmacologic therapy for patients with diabetes and hypertension. A regimen that includes either an ACE inhibitor or angiotensin II receptor blocker. If one class is not tolerated, the other should be substituted. Multiple drug therapy (two or more agents at maximal doses) is generally required to achieve blood pressure targets (B) This set of seven slides summarize recommendations for screening and diagnosis, goals, and treatment for hypertension/blood pressure control in patients with diabetes. Slide 6 of 7 \u2013 Treatment (Slide 4 of 5) Pharmacologic therapy for patients with diabetes and hypertension should be paired with a regimen that included either an ACE inhibitor or an angiotensin II receptor blocker (ARB); if one class is not tolerated, the other should be substituted. Multiple drug therapy (two or more agents at maximal doses) is generally required to achieve blood pressure targets (B) ADA. VI. Prevention, Management of Complications. Diabetes Care 2012;35(suppl 1):S29. Reference. American Diabetes Association. Standards of medical care in diabetes\u20142012. Diabetes Care 2012;35(suppl 1):S29.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}